Register Cart 0

Generic placeholder image

Current Pharmacogenomics and Personalized Medicine

Editor-in-Chief

ISSN (Print): 1875-6921
ISSN (Online): 1875-6913

Back Subscribe

Biography

Meet Our Editorial Board Member

Author(s): Ari Hirvonen*

Volume 14, Issue 2, 2016

Page: [65 - 65] Pages: 1

DOI: 10.2174/187569211402170424204837

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

14

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
Current Drug Targets - CNS & Neurological Disorders

Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry

Ligand and Structure-Based Drug Design as Strategies for the Screening of New BACE1 Inhibitor Candidates
Current Physical Chemistry

Commentary (Research Highlights: The Genetic Basis of “Running for Longevity”)
CNS & Neurological Disorders - Drug Targets

EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Current Molecular Pharmacology

Computational Evidence for the Reactivation Process of Human Acetylcholinesterase Inhibited by Carbamates
Combinatorial Chemistry & High Throughput Screening

Transcranial Magnetic Stimulation of Degenerating Brain: A Comparison of Normal Aging, Alzheimer’s, Parkinson’s and Huntington's Disease
Current Alzheimer Research

Flavonoids and Polyphenolic Compounds as Potential Talented Agents for the Treatment of Alzheimer’s Disease and their Antioxidant Activities
Current Pharmaceutical Design

The Cannabinergic System as a Target for Anti-inflammatory Therapies
Current Topics in Medicinal Chemistry

Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone
Current Medicinal Chemistry

Risk Factors for Cardiovascular Disease in Psoriasis: Relation to Inflammation Assessed by the Severity and Duration of Illness
Inflammation & Allergy - Drug Targets (Discontinued)

Cytokines in Systemic Lupus Erythematosus
Current Molecular Medicine

Cerebral Artery Vasoconstriction is Endothelin-1 Dependent Requiring Neurogenic and Adrenergic Crosstalk
Current Neurovascular Research

In Vitro Metabolism Studies of New Adenosine A Receptor Antagonists
Drug Metabolism Letters

Influence of Genetic Background on Apathy-Like Behavior in Triple Transgenic AD Mice
Current Alzheimer Research

Functional and Molecular Ultrasound Imaging: Concepts and Contrast Agents
Current Medicinal Chemistry

PDGF Receptor β Signaling in Pericytes Following Ischemic Brain Injury
Current Neurovascular Research

Phytochemicals to Prevent Inflammation and Allergy
Recent Patents on Inflammation & Allergy Drug Discovery

Two-Dimensional QSAR Studies on Arylpiperazines as High-Affinity 5-HT1A Receptor Ligands
Medicinal Chemistry

Structure-Based Approaches in the Design of GSK-3 Selective Inhibitors
Current Protein & Peptide Science

© 2024 Bentham Science Publishers | Privacy Policy